Regional Gene Expression in the Retina, Optic Nerve Head, and Optic Nerve of Mice with Experimental Glaucoma and Optic Nerve Crush.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
25 May 2023
25 May 2023
Historique:
pubmed:
31
3
2023
medline:
31
3
2023
entrez:
30
3
2023
Statut:
epublish
Résumé
A major risk factor for glaucomatous optic neuropathy is the level of intraocular pressure (IOP), which can lead to retinal ganglion cell axon injury and cell death. The optic nerve has a rostral unmyelinated portion at the optic nerve head followed by a caudal myelinated region. The unmyelinated region is differentially susceptible to IOP-induced damage in rodent models and in human glaucoma. While several studies have analyzed gene expression changes in the mouse optic nerve following optic nerve injury, few were designed to consider the regional gene expression differences that exist between these distinct areas. We performed bulk RNA-sequencing on the retina and on separately micro-dissected unmyelinated and myelinated optic nerve regions from naïve C57BL/6 mice, mice after optic nerve crush, and mice with microbead-induced experimental glaucoma (total = 36). Gene expression patterns in the naïve unmyelinated optic nerve showed significant enrichment of the Wnt, Hippo, PI3K-Akt, and transforming growth factor β pathways, as well as extracellular matrix-receptor and cell membrane signaling pathways, compared to the myelinated optic nerve and retina. Gene expression changes induced by both injuries were more extensive in the myelinated optic nerve than the unmyelinated region, and greater after nerve crush than glaucoma. Changes three and fourteen days after injury largely subsided by six weeks. Gene markers of reactive astrocytes did not consistently differ between injury states. Overall, the transcriptomic phenotype of the mouse unmyelinated optic nerve was significantly different from immediately adjacent tissues, likely dominated by expression in astrocytes, whose junctional complexes are inherently important in responding to IOP elevation.
Identifiants
pubmed: 36993314
doi: 10.1101/2023.02.21.529410
pmc: PMC10054954
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NEI NIH HHS
ID : P30 EY001765
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY002120
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009518
Pays : United States
Organisme : NEI NIH HHS
ID : R56 EY002120
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1247-58
pubmed: 15037594
Mol Cell. 2016 Apr 7;62(1):104-10
pubmed: 27041223
Nat Commun. 2020 Mar 5;11(1):1220
pubmed: 32139688
PLoS One. 2012;7(9):e45613
pubmed: 23049825
Physiol Genomics. 2004 Apr 13;17(2):157-69
pubmed: 14747662
Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4220-33
pubmed: 22570341
J Neurosci. 2017 Jun 21;37(25):6113-6124
pubmed: 28539419
F1000Res. 2019 Nov 7;8:1874
pubmed: 33552473
J Cell Biol. 2007 Dec 31;179(7):1523-37
pubmed: 18158332
Genes (Basel). 2022 Jun 13;13(6):
pubmed: 35741817
Glia. 2004 Mar;45(4):364-77
pubmed: 14966868
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188556
pubmed: 33932560
Vet J. 2011 Nov;190(2):e72-e77
pubmed: 21330168
Glia. 2013 Aug;61(8):1218-35
pubmed: 23650091
Nat Neurosci. 2015 Jul;18(7):942-52
pubmed: 26108722
Neurochem Res. 2020 Jun;45(6):1298-1305
pubmed: 32006215
Mov Disord. 2019 Jul;34(7):959-969
pubmed: 31136698
Nature. 2011 Jul 20;475(7356):316-23
pubmed: 21776077
iScience. 2022 Nov 13;25(12):105568
pubmed: 36465110
Science. 2022 Nov 4;378(6619):eadc9020
pubmed: 36378959
Invest Ophthalmol Vis Sci. 2011 Jan 25;52(1):504-18
pubmed: 20847120
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Exp Eye Res. 2020 Jul;196:108035
pubmed: 32353427
Prog Retin Eye Res. 2005 Mar;24(2):217-40
pubmed: 15610974
Nat Neurosci. 2021 Oct;24(10):1475-1487
pubmed: 34413515
Arch Ophthalmol. 1999 Aug;117(8):1050-6
pubmed: 10448748
J Clin Invest. 2011 Apr;121(4):1429-44
pubmed: 21383504
PLoS One. 2020 Aug 21;15(8):e0238104
pubmed: 32822415
J Glaucoma. 2007 Jun-Jul;16(4):406-18
pubmed: 17571004
Nature. 2021 Nov;599(7883):102-107
pubmed: 34616039
Br J Pharmacol. 2022 Feb;179(4):715-726
pubmed: 34519040
J Neuroinflammation. 2020 Aug 28;17(1):252
pubmed: 32859212
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Biochem Biophys Res Commun. 2015 Nov 13;467(2):367-72
pubmed: 26431871
J Exp Med. 2017 May 1;214(5):1411-1430
pubmed: 28416649
Prog Retin Eye Res. 2014 Nov;43:17-75
pubmed: 25038518
Arch Ophthalmol. 1981 Apr;99(4):635-49
pubmed: 6164357
PLoS One. 2021 Feb 2;16(2):e0244123
pubmed: 33529207
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
Acta Neuropathol. 2021 Nov;142(5):899-915
pubmed: 34487221
Neuron. 2017 Aug 2;95(3):531-549.e9
pubmed: 28712653
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
J Neuroinflammation. 2021 Dec 24;18(1):303
pubmed: 34952606
Acta Neuropathol Commun. 2019 Jul 31;7(1):125
pubmed: 31366377
Nat Med. 2006 Jul;12(7):829-34
pubmed: 16783372
Cell Rep. 2020 Jun 23;31(12):107776
pubmed: 32579912
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Optom Vis Sci. 2008 Jun;85(6):425-35
pubmed: 18521012
J Comp Neurol. 2009 Sep 1;516(1):1-19
pubmed: 19562764
PLoS One. 2013 Jun 27;8(6):e67094
pubmed: 23826199
Int J Mol Sci. 2020 Sep 30;21(19):
pubmed: 33007835
Nat Commun. 2018 Apr 24;9(1):1623
pubmed: 29691400
Annu Rev Neurosci. 2019 Jul 8;42:187-207
pubmed: 31283899
J Neurochem. 2017 Jul;142(2):323-337
pubmed: 28498493
PLoS One. 2022 Jun 16;17(6):e0268541
pubmed: 35709078
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):14
pubmed: 32910133
Glia. 1997 Jul;20(3):262-73
pubmed: 9215735
Dev Biol. 2021 Oct;478:144-154
pubmed: 34260962
Neurochem Res. 2023 Apr;48(4):1222-1232
pubmed: 35930103
Nat Rev Cancer. 2016 Apr;16(4):251-65
pubmed: 27009395
Front Physiol. 2018 Jul 05;9:824
pubmed: 30026699
Trans Am Ophthalmol Soc. 2006;104:453-77
pubmed: 17471356
Glia. 2010 May;58(7):780-9
pubmed: 20091782
Biochemistry (Mosc). 2000 Jan;65(1):28-40
pubmed: 10702638
Mol Vis. 2013 Sep 26;19:2023-39
pubmed: 24146537
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3161-77
pubmed: 17591886